<VariationArchive RecordType="classified" VariationID="1707600" VariationName="NM_001271.4(CHD2):c.2324_2328del (p.Glu775fs)" VariationType="Deletion" Accession="VCV001707600" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-08-06" DateCreated="2022-10-08" MostRecentSubmission="2022-10-08">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1705905" VariationID="1707600">
      <GeneList>
        <Gene Symbol="CHD2" FullName="chromodomain helicase DNA binding protein 2" GeneID="1106" HGNC_ID="HGNC:1917" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>15q26.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="92900324" stop="93027996" display_start="92900324" display_stop="93027996" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="93443550" stop="93571236" display_start="93443550" display_stop="93571236" Strand="+" />
          </Location>
          <OMIM>602119</OMIM>
          <Haploinsufficiency last_evaluated="2019-10-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CHD2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2019-10-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CHD2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001271.4(CHD2):c.2324_2328del (p.Glu775fs)</Name>
      <CanonicalSPDI>NC_000015.10:92971897:GAAAGG:G</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>15q26.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="92971898" stop="92971902" display_start="92971898" display_stop="92971902" variantLength="5" positionVCF="92971897" referenceAlleleVCF="TGAAAG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="93515128" stop="93515132" display_start="93515128" display_stop="93515132" variantLength="5" positionVCF="93515127" referenceAlleleVCF="TGAAAG" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>E775fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1425" sequenceAccession="LRG_1425">
            <Expression>LRG_1425:g.76579_76583del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1425t1" sequenceAccession="LRG_1425t1">
            <Expression>LRG_1425t1:c.2324_2328del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1425p1" sequenceAccession="LRG_1425p1" change="p.Glu775fs">
            <Expression>LRG_1425p1:p.Glu775fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.92971899_92971903del" Assembly="GRCh38">
            <Expression>NC_000015.10:g.92971899_92971903del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.93515129_93515133del" Assembly="GRCh37">
            <Expression>NC_000015.9:g.93515129_93515133del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012826.2" sequenceAccession="NG_012826" sequenceVersion="2" change="g.76579_76583del">
            <Expression>NG_012826.2:g.76579_76583del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001271.4" sequenceAccession="NM_001271" sequenceVersion="4" change="c.2324_2328del" MANESelect="true">
            <Expression>NM_001271.4:c.2324_2328del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001262.3" sequenceAccession="NP_001262" sequenceVersion="3" change="p.Glu775fs">
            <Expression>NP_001262.3:p.Glu775fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001271.4" sequenceAccession="NM_001271" sequenceVersion="4" change="c.2323_2327del" MANESelect="true">
            <Expression>NM_001271.4:c.2323_2327del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <FunctionalConsequence Value="protein truncation">
        <XRef ID="0015" DB="Variation Ontology" />
      </FunctionalConsequence>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001271.4(CHD2):c.2324_2328del (p.Glu775fs) AND Developmental and epileptic encephalopathy 94" Accession="RCV002286557" Version="1">
        <ClassifiedConditionList TraitSetID="11671">
          <ClassifiedCondition DB="MedGen" ID="C3809278">Developmental and epileptic encephalopathy 94</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-08-05" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-08-05" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-10-08" MostRecentSubmission="2022-10-08">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="11671" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18237" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Epileptic encephalopathy, childhood-onset</ElementValue>
                <XRef ID="MONDO:0014150" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Developmental and epileptic encephalopathy 94</ElementValue>
                <XRef ID="MONDO:0014150" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DEE94</ElementValue>
                <XRef Type="MIM" ID="615369" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13197" />
                <XRef ID="13197" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">CHD2-related neurodevelopmental disorders are characterized by early-onset epileptic encephalopathy (i.e., refractory seizures and cognitive slowing or regression associated with frequent ongoing epileptiform activity). Seizure onset is typically between ages six months and four years. Seizure types typically include drop attacks, myoclonus, and rapid onset of multiple seizure types associated with generalized spike-wave on EEG, atonic-myoclonic-absence seizures, and clinical photosensitivity. Intellectual disability and/or autism spectrum disorders are common.</Attribute>
                <XRef ID="NBK333201" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">26677509</ID>
                <ID Source="BookShelf">NBK333201</ID>
              </Citation>
              <XRef ID="1942" DB="Orphanet" />
              <XRef ID="2382" DB="Orphanet" />
              <XRef ID="C3809278" DB="MedGen" />
              <XRef ID="MONDO:0014150" DB="MONDO" />
              <XRef Type="MIM" ID="615369" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5037268" SubmissionDate="2022-09-24" DateLastUpdated="2022-10-08" DateCreated="2022-10-08">
        <ClinVarSubmissionID localKey="SUB12094294" submittedAssembly="GRCh38" title="SUB12094294" />
        <ClinVarAccession Accession="SCV002574907" DateUpdated="2022-10-08" DateCreated="2022-10-08" Type="SCV" Version="1" SubmitterName="Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics" OrgID="505565" OrganizationCategory="other" OrgAbbreviation="FRIGE - IHG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>A heterozygous missense variation in exon 18 of the CDH1 gene that results in a frameshift and premature truncation of the protein 49 amino acids downstream to codon 775 was detected. The observed variant c.2323_2327del (p.Glu775GlyfsTer49) has not been reported in the 1000 genomes and gnomAD databases. The in silico prediction of the variant is benign by PolyPhen-2 (HumDiv), SIFT and MutationTaster2. The reference codon is conserved across mammals. In summary, the variant meets our criteria to be classified as a variant of pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">10</Age>
              <Age Type="maximum" age_unit="years">19</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
              <Indication Type="Indication">
                <Trait Type="Finding">
                  <Name>
                    <ElementValue Type="Preferred">Previous child affected with Developmental and epileptic encephalopathy 94</ElementValue>
                  </Name>
                </Trait>
              </Indication>
            </Sample>
            <Method>
              <NamePlatform>Illumina sequencing platform</NamePlatform>
              <Description>DNA was used to perform targeted gene capture using a custom capture kit. Libraries were sequenced to mean &gt;80-100X coverage on Illumina sequencing platform. Sequence obtained were aligned to human references genome using BWA program and analyzed using Picard and GATK-Lite toolkit to identify variants in the targeted genes relevant to clinical indication</Description>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">whole exome</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet DateLastEvaluated="2022-08-05" Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001250" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001249" />
              </Trait>
              <Comment>Attention deficit hyperactivity disorder at 3 years of age.</Comment>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CHD2">
              <Name>chromodomain helicase DNA binding protein 2</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_001271.4:exon 18</GeneLocation>
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">D-6944</Name>
          </OtherNameList>
          <FunctionalConsequence Value="protein truncation">
            <XRef DB="Variation Ontology" ID="0015" URL="http://purl.obolibrary.org/obo/VariO_0015" />
          </FunctionalConsequence>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001271.4:c.2323_2327del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="615369" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12094294</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5037268" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001250" MappingRef="HP">
        <MedGen CUI="C0036572" Name="Seizure" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5037268" TraitType="Disease" MappingType="XRef" MappingValue="615369" MappingRef="OMIM">
        <MedGen CUI="C3809278" Name="Developmental and epileptic encephalopathy 94" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5037268" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001249" MappingRef="HP">
        <MedGen CUI="C3714756" Name="Intellectual disability" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

